Article

Pneumococcal vaccines and flu preparedness

Emory University, Atlanta, Georgia, United States
Science (Impact Factor: 31.48). 05/2007; 316(5821):49-50. DOI: 10.1126/science.316.5821.49c
Source: PubMed
1 Follower
 · 
82 Views
  • South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 08/2011; 101(8):587-595. · 1.71 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Influenza viruses are genetically labile pathogens which avoid immune detection by constantly changing their coat proteins. Most human infections are caused by mildly pathogenic viruses which rarely cause life-threatening disease in healthy people, but some individuals with a weakened immune system can experience severe complications. Widespread infections with highly pathogenic strains of influenza virus are less common, but have the potential to cause enormous death tolls among healthy adults if infection rates reach pandemic proportions. Increased virulence has been attributed to a variety of factors, including enhanced susceptibility to coinfection with common strains of bacteria. The mechanisms that facilitate dual infection are a major focus of current research, as preventative measures are needed to avert future pandemics.
    Discovery medicine 01/2015; 19(102):33-40. · 3.50 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Vaccine probe studies have emerged in the past 15 years as a useful way to characterise disease. By contrast, traditional studies of vaccines focus on defining the vaccine effectiveness or efficacy. The underlying basis for the vaccine probe approach is that the difference in disease burden between vaccinated and unvaccinated individuals can be ascribed to the vaccine-specific pathogen. Vaccine probe studies can increase understanding of a vaccine's public health value. For instance, even when a vaccine has a seemingly low efficacy, a high baseline disease incidence can lead to a large vaccine-preventable disease burden and thus that population-based vaccine introduction would be justified. So far, vaccines have been used as probes to characterise disease syndromes caused by Haemophilus influenzae type b, pneumococcus, rotavirus, and early infant influenza. However, vaccine probe studies have enormous potential and could be used more widely in epidemiology, for example, to define the vaccine-preventable burden of malaria, typhoid, paediatric influenza, and dengue, and to identify causal interactions between different pathogens.
    The Lancet 02/2014; 383(9930). DOI:10.1016/S0140-6736(13)61682-7 · 39.21 Impact Factor